References
- Bella M, Milata V, Larina L (2012) J. Heterocycl. Chem. 49(2): 293—296.
- Couchouron B, Le Saint J, Courtot P (1983) Bull. Soc. Chim. Fr. 66—72.
- Ellis GP, Jones RT (1974) J. Chem. Soc. Perkin Trans 1, 903—909.
- Guyton KZ, Rusyn I, Chiu WA, Corpet DE, van den Berg M, Ross MK, Christiani DC, Beland FA, Smith MT (2018) Carcinogenesis 39: 614—622.
- Ilavský D, Bobošík V, Martvoň A (1985) Chem. Pap. 39(4): 527—536.
- Ishiwata S, Shiokawa Y (1969) Chem. Pharm. Bull. 17(12): 2455—2460.
- Lakshmi VM, Hsu FF, Zenser TV (2004) Chem. Res. Toxicol. 17(5): 709—716.
- Li J-J (2005) Name Reactions in Heterocyclic Chemistry, John Wiley and Sons, New Jersey, ISBN 0-47130215-5.
- Milata V, Ilavský D (1987) Coll. Czechoslov. Chem. Commun. 52: 2918—2925.
- Milata V, Ilavský D, Leško J (1988) Coll. Czechoslov. Chem. Commun. 53: 1068—1077.
- Milata V, Ilavský D, Leško J (1998) Coll. Czechoslov. Chem. Commun. 53: 1068—1077.
- Milata V, Ilavský D, Goljer I, Leško J, Chahinian M, Henry-Basch E (1989) Coll. Czechoslov. Chem. Commun. 55: 1038—1048.
- Milata V, Ilavsky D, Goljer I, Zalibera Ľ (1994) Coll. Czechoslov. Chem. Commun. 59: 1145—1152.
- Milata V, Claramunt RM, Elguero J, Zálupský P (2000) Targets in Heterocyclic Systems: 4: 167—203.
- Milata V (2001) Tricyclic Azoloquinolines in: Advances in Heterocyclic Chemistry, ed. A.R. Katritzky, Academic Press, San Diego 78: 189—268.
- Saloň J, Milata V, Gatial A, Prónayová N, Leško J, Černuchová P, Vo-Thanh G, Loupy A (2005) Eur. J. Org. Chem. 22: 4870—4878.
- Waterhouse AL, Rapoport H (1985) J. Labelled Compds. Radiopharm. 22: 201—216.